Bioline Rx's total assets for Q1 2025 were $43.51M, an increase of 11.83% from the previous quarter. IL:BLRX total liabilities were $22.65M for the fiscal quarter, a -10.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.